Cargando…
Evidence for impaired amyloid β clearance in Alzheimer's disease
Alzheimer's disease (AD) is a common neurodegenerative disease characterized by the accumulation of extracellular plaques and intracellular tangles. Recent studies support the hypothesis that the accumulation of amyloid beta (Aβ) peptide within the brain arises from an imbalance of the producti...
Autores principales: | Wildsmith, Kristin R, Holley, Monica, Savage, Julie C, Skerrett, Rebecca, Landreth, Gary E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978761/ https://www.ncbi.nlm.nih.gov/pubmed/23849219 http://dx.doi.org/10.1186/alzrt187 |
Ejemplares similares
-
Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015) -
Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020) -
Nogo receptor impairs the clearance of fibril amyloid‐β by microglia and accelerates Alzheimer’s‐like disease progression
por: Wang, Jianing, et al.
Publicado: (2021) -
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling
por: Basak, Jacob M, et al.
Publicado: (2012) -
Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)